XFXavier Gabriel Fopokam

Xavier Gabriel Fopokam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xavier Gabriel Fopokam has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors of smart pillboxes adoption intent among people living with HIV in Cameroon: a cross-sectional study

    by Armel F. Setubi, Bryan Shaw, Katherine Robsky, Ignace Gashongore, Michael Ochieng Otieno, Vinie Kouamou, Xavier Gabriel Fopokam, Rhonda BeLue, Joy Musa Shallangwa, Deus Bazira, et al.

    Background: Maintaining high levels of medication adherence is essential for the success of antiretroviral therapy (ART), yet non-adherence remains a persistent challenge in resource-limited settings. Smart Pillboxes (SPBs) offer a promising digital solution by providing real-time adherence monitoring and clinical decision support. However, the successful implementation of these tools among people living with HIV (PLHIV) depends on understanding user-level barriers. This study examines the sociodemographic, behavioral, and infrastructural factors that influence the willingness to adopt SPBs among people living with HIV in Cameroon. Methods: This cross-sectional study involved 153 PLHIV recruited from clinical sites in the Center Region of Cameroon. The Diffusion of Innovations (DOI) framework informed the conceptual categorization. Due to convergence issues with log-binomial models, statistical analyses utilized multivariable modified Poisson regressions with robust standard errors to identify predictors of adoption intent. Global model significance was assessed via the Wald Chi-square test. A bootstrap procedure was applied to validate the stability of identified predictors. Results: At the outset, 60.8% of participants self-classified as adopters. Females were the majority (53%), and over half of the participants were single (55.6%). The final multivariable model demonstrated high statistical significance (Wald $$\:{\chi\:}^{2}$$ = 29.5, p = 0.0019). Higher educational attainment (MA; aRR = 1.64, p = 0.004) and frequent medication forgetfulness (aRR = 1.35, p = 0.026) were identified as robust facilitators of adoption willingness. Adoption intent was significantly attenuated by the use of phone reminders (aRR = 0.77, p = 0.049) and unemployment (aRR = 0.64, p = 0.049). Conclusion: Adoption intent of SPBs is driven by a synergy of socioeconomic status and felt behavioral needs. While infrastructure is a necessary baseline, educational attainment and perceived utility are the primary determinants of adoption intent in this urban population.

  • Open Access

    Exploring the Antidiabetic Properties of Polyalthia longifolia Leaf and Stem Extracts: In Vitro α-Glucosidase and Glycation Inhibition

    by Guglielmina Froldi, Marguerite Kamdem Simo, Laura Tomasi, Giulia Tadiotto, Francine Medjiofack Djeujo, Xavier Gabriel Fopokam, Emmanuel Souana, Modeste Lambert Sameza, Pierre Michel Jazet, Fabrice Fekam Boyom

    Polyalthia longifolia, a member of the Annonaceae family, is traditionally used for its medicinal properties, including as an antidiabetic remedy, primarily in Asia and sub-Saharan Africa. This study investigated the potential of six P. longifolia extracts in counteracting hyperglycemia and diabetes-related complications. Aqueous, ethanol, and methanol extracts from leaves and stems were evaluated for their antihyperglycemic, antiglycation, and antiradical properties using α-glucosidase, BSA, and ORAC assays, respectively. Phytochemical characterization was conducted using TPC and TFC assays, and HPLC analysis identified specific bioactive compounds, including various phenolic compounds (gallic acid, (+)-catechin, epicatechin, caffeic acid, ellagic acid and rosmarinic acid) and flavonoids (luteolin, kaempferol and baicalein). The MTT assay on the human cell line HT-29 assessed the activity of extracts on cell viability, showing slight cytotoxicity. Results demonstrated significant antidiabetic activity of the ethanol and methanol extracts from P. longifolia leaves. This study provides new insights into the potential use of P. longifolia in diabetes mellitus and supports the valorization of traditional medicinal plants.


  • Open Access

    Antidiabetic Properties of Polyalthia longifolia: A Comprehensive In Vitro Study of Leaf and Stem Extracts

    by Guglielmina Froldi, Marguerite Kamdem Simo, Laura Tomasi, Giulia Tadiotto, Francine Medjiofack Djeujo, Xavier Gabriel Fopokam, Emmanuel Souana, Modeste Lambert Sameza, Pierre Michel Jazet, Fabrice Fekam Boyom

    Polyalthia longifolia, a member of the Annonaceae family, is traditionally used for its medicinal properties, including as an antidiabetic remedy, primarily in Asia and sub-Saharan Africa. This study investigated the potential of six P. longifolia extracts in counteracting hyperglycemia and diabetes-related complications. Aqueous, ethanol, and methanol extracts from leaves and stems were evaluated for their antihyperglycemic, antiglycation, and antiradical properties using α-glucosidase, BSA, and ORAC assays, respectively. Phytochemical characterization was conducted using TPC and TFC assays, and HPLC analysis identified specific bioactive compounds, including various phenolic compounds and flavonoids (mainly baicalein). The MTT assay on the human cell line HT-29 assessed the activity of extracts on cell viability, showing slight cytotoxicity. Results demonstrated significant antidiabetic activity of the ethanol and methanol extracts from P. longifolia leaves. This study provides new insights into the potential use of P. longifolia in diabetes mellitus and supports the valorization of traditional medicinal plants.

  • Open Access

    New Insights into the Antimicrobial Potential of Polyalthia longifolia—Antibiofilm Activity and Synergistic Effect in Combination with Penicillin against Staphylococcus aureus

    by Mihaela Savu, Marguerite Kamdem Simo, Gabriel Xavier Fopokam, Stefan Mihaita Olaru, Oana Cioanca, Fabrice Fekam Boyom, Marius Stefan

    Widespread antibiotic resistance has led to the urgent need for the identification of new antimicrobials. Plants are considered a valuable potential resource for new effective antimicrobial compounds. Therefore, in the present study, we focused on the antimicrobial activity of Polyalthia longifolia plants harvested from Cameroon using the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill assays. The mechanism of action was investigated by employing fluorescence and scanning electron microscopy. The anti-Staphylococcus aureus activity was studied using biofilm inhibition and checkerboard assays. Our results revealed that the tested extracts possess important antimicrobial activities, notably against Gram positive bacteria (MICs as low as 0.039 mg/mL). P. longifolia leaf extracts exhibited a significant bactericidal effect, with a total kill effect recorded after only 2 h of exposure at concentrations equivalent to MBC (0.078 and 0.156 mg/mL). The extracts showed a synergistic antibacterial activity in combination with penicillin against a MRSA clinical isolate and significantly inhibited S. aureus biofilm formation. The mechanism of action is related to the impairment of cell membrane integrity and cell lysis. All these findings suggest that P. longifolia could be an important source of reliable compounds used to develop new antimicrobials.